Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Boston, Massachusetts


Purpose:

The purpose of the study is to evaluate the efficacy of Seprafilm in reducing the incidence of bowel obstruction and to evaluate the incidence of all serious adverse events (SAEs) associated with the use of Seprafilm occurring within 30 days postoperatively, and the incidence of abdominopelvic abscess within 6 months postoperatively.


Criteria:

Inclusion Criteria: - Patients who were undergoing colon and/or rectal resections and/or adhesiolysis for treatment of bowel obstruction Exclusion Criteria: - Patients with any medical condition or disease where 5-year survival was not expected - Patients undergoing laparoscopy - Patients undergoing surgery for treatment of acute abdominal trauma - Patients with an abscess (abdominal or pelvic) present during the initial surgery - Patients with a history of pulmonary embolus or deep vein thrombosis (DVT) within 1 year of surgery


NCT ID:

NCT00130715


Primary Contact:

N/A


Backup Contact:

N/A


Location Contact:

Boston, Massachusetts
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: November 18, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.